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ARTICLE
Myelinating Schwann cells ensheath multiple axons
in the absence of E3 ligase component Fbxw7
Breanne L. Harty1,2,3, Fernanda Coelho 3, Sarah E. Pease-Raissi4, Amit Mogha3, Sarah D. Ackerman2,7,
Amy L. Herbert2,8, Robert W. Gereau IV 5, Judith P. Golden5, David A. Lyons 6, Jonah R. Chan 4 &
Kelly R. Monk2,3
In the central nervous system (CNS), oligodendrocytes myelinate multiple axons; in the
peripheral nervous system (PNS), Schwann cells (SCs) myelinate a single axon. Why are the
myelinating potentials of these glia so fundamentally different? Here, we find that loss of
Fbxw7, an E3 ubiquitin ligase component, enhances the myelinating potential of SCs. Fbxw7
mutant SCs make thicker myelin sheaths and sometimes appear to myelinate multiple axons
in a fashion reminiscent of oligodendrocytes. Several Fbxw7 mutant phenotypes are due to
dysregulation of mTOR; however, the remarkable ability of mutant SCs to ensheathe multiple
axons is independent of mTOR signaling. This indicates distinct roles for Fbxw7 in SC biology
including modes of axon interactions previously thought to fundamentally distinguish mye-
linating SCs from oligodendrocytes. Our data reveal unexpected plasticity in the myelinating
potential of SCs, which may have important implications for our understanding of both PNS
and CNS myelination and myelin repair.
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In vertebrates, oligodendrocytes (OLs) and Schwann cells (SCs)are specialized glial cells that generate the myelin sheaths ofthe central nervous system (CNS) and peripheral nervous
system (PNS), respectively. In both the CNS and PNS myelin
enables fast action potential propagation and protects the axon
that it surrounds1. Myelin sheaths of the CNS and PNS are
broadly similar in composition and structure, and there is a large
degree of overlap in the molecular control of myelination by OLs
and myelinating SCs2,3. However, there are important differences
in how OLs and SCs interact with axons. One major fundamental
difference between OLs and myelinating SCs is the ratio by which
they myelinate axons. In peripheral nerves, SCs select specific
axons in a process called radial sorting, whereby they are thought
to extend exploratory processes into a bundle of unmyelinated
axons and select just one axon, >1 μm in diameter, for myelina-
tion. Upon completion of radial sorting, promyelinating SCs are
associated 1:1 with large-caliber axons (>1 μm in diameter),
whereupon they initiate formation of a myelin sheath. In contrast,
multiple small-caliber axons in peripheral nerves are ensheathed
by non-myelinating Remak SCs into Remak bundles. The
mechanisms controlling the Remak SC vs. myelinating SC fate are
unclear. In the CNS, OLs also extend exploratory processes that
dynamically interact with potential target axons4, but unlike SCs,
OLs are able to myelinate many axon segments5. Given the broad
molecular similarities between myelinating SCs and OLs, it is
unclear why SCs and OLs exhibit such differences in myelinating
capacity.
The E3 ubiquitin ligase component F-box and WD-repeat
domain containing 7 (Fbxw7) is an important regulator of OL
development and CNS myelination6–8. Here, using SC-specific
knockout approaches in mice, we demonstrate that Fbxw7 plays
distinct roles in SCs. Of principal interest is that, in the absence
of Fbxw7, SCs appear to gain the ability to myelinate multiple
axons in a fashion reminiscent of OLs in vivo and in vitro. Also
surprising was the apparent ability of Fbxw7 mutant SCs to
generate myelin around large-caliber axons while simultaneously
ensheathing many additional small-caliber axons. Electron
microscopy and immunofluorescence analyses confirm that these
cells are indeed SCs and not OLs that may have infiltrated the
PNS. In addition, Fbxw7 mutants display early increases in SC
number, smaller Remak bundles, and hypermyelination which are
ameliorated upon loss of mTOR. However, even in the absence of
mTOR, Fbxw7 mutant SCs appear to retain the ability to mye-
linate multiple axons, as well as simultaneously myelinate large
axons while ensheathing small unmyelinated axons. This suggests
that the molecular mechanisms that regulate the fundamental
difference in myelinating potential between SCs and OLs are
independent of mTOR signaling. Taken together, our findings
show that the restriction of myelinating SCs to myelinate a single
axon may be mutable and that Fbxw7 is a critical player in reg-
ulating the myelinating potential of SCs.
Results
Fbxw7 cell-autonomously regulates SC development. Fbxw7 is a
substrate recognition component of SKP1-Cullin-F-box (SCF)
ubiquitin ligase complexes, which catalyze addition of ubiquitin
moieties on certain proteins to target them for proteasomal
degradation9. We and others have previously reported that fbxw7
zebrafish mutants display striking overexpression of myelin basic
protein (mbp) in the CNS, enhanced OL numbers and thicker
CNS myelin6–8.
Given the role of Fbxw7 in OLs, and the overlap in
developmental programs that regulate OL versus SC maturation,
we hypothesized that Fbxw7 is also required in SCs. To test this,
we employed a conditional knockout strategy in mice. The Dhhcre
transgene results in Cre recombinase expression under the Desert
hedgehog promoter at approximately embryonic day (E) 12.5 in
SC precursors10. To delete Fbxw7 specifically in SCs, we crossed
Dhhcre with an Fbxw7fl/fl transgenic line in which loxP sites flank
exons 5 and 6 of Fbxw711. This creates a frameshift upon Cre
activity resulting in a null allele, which we confirmed using RT-
PCR to visualize the absence of mRNA (Supplementary Fig. 1a).
Dhhcre(+);Fbxw7fl/fl conditional mutants were viable, fertile, and
appeared grossly normal compared with controls. In all cases,
Dhhcre(−);Fbxw7fl/+ and Dhhcre(−);Fbxw7fl/fl siblings were used as
controls.
We analyzed sciatic nerves by transmission electron microscopy
(TEM) and found that at postnatal day 3 (P3), heterozygous
Dhhcre(+);Fbxw7fl/+ (Het) and homozygous Dhhcre(+);Fbxw7fl/fl
(cKO) mutant mice displayed an increase in SC nuclei relative to
controls (Fig. 1a–d). However, by P42, SC numbers were
equivalent in mutant and wild-type nerves (Fig. 1f–i), demonstrat-
ing that the early increase in SC number in Fbxw7 mutants is
transient. Dhhcre(+);Fbxw7fl/+ and Dhhcre(+);Fbxw7fl/fl nerves also
had a higher proportion of myelinated axons relative to control
nerves (Fig. 1e, j), although there were no significant changes in
total axon numbers, (Supplementary Fig. 1b).
The myelin was also considerably thicker in Dhhcre(+);Fbxw7fl/+
and Dhhcre(+);Fbxw7fl/fl mice compared with controls beginning at
P21, especially on small-caliber axons (Fig. 1k–n, Supplementary
Fig. 1c, d). Importantly, however, mutant SCs do not appear to be
myelinating axons <1 μm in diameter any more frequently than
control SCs. This suggests that Fbxw7 mutant SCs are able to
respond appropriately to Neuregulin signaling12,13. Finally, we
found that Remak bundles contained fewer axons in Dhhcre(+);
Fbxw7fl/+ and Dhhcre(+);Fbxw7fl/fl nerves relative to controls
(Supplementary Fig. 1e–s). These data demonstrate that Fbxw7
functions cell-autonomously to regulate multiple aspects of SC
development.
Fbxw7 mutant Schwann cells appear to myelinate multiple
axons. We also found that loss of Fbxw7 dramatically increased
the myelinating potential of SCs (Fig. 2, Supplementary Figs. 2
and 3). In every Dhhcre(+);Fbxw7fl/+ and Dhhcre(+);Fbxw7fl/fl
nerve examined, even in adulthood, we observed numerous
instances of what appeared to be multi-axonal myelination
(Fig. 2b, c, f, j, k; Supplementary Fig. 2a–e). These myelinated
axons were sometimes joined by long thin processes of SC
cytoplasm in a manner reminiscent of OL myelination (Fig. 2j,
red arrow).
We also observed Fbxw7 mutant SCs that had myelinated one
or more axons and appeared to simultaneously encompassed
several unmyelinated axons in an immature SC or Remak SC-like
fashion (Fig. 2d–f; Supplementary Fig. 2f–j). When mature, these
SCs displayed both myelinating SC and Remak SC qualities
almost as though these cells are myelinating/Remak SC hybrids,
with the myelin being grossly normal and every unmyelinated
axon being fully ensheathed by SC membrane and cytoplasm
(Fig. 2h, Supplementary Fig. 2h–j). Importantly, both of these
distinct phenotypes were observed at all developmental stages
examined—P3, P21, P42, and P150–180—suggesting that they are
not simply transient developmental anomalies. It is also
important to highlight that these phenotypes are distinct from
polyaxonal myelination, in which a bundle of axons is myelinated
together as though it was one larger axon (Supplementary
Fig. 2k), which has been previously reported in mutants with
radial sorting defects and occurs at low frequency even in wild-
type nerves14.
In total, by cross-sectional TEM analyses, ~12% of Fbxw7
mutant SCs display enhanced myelinating potential, and this
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proportion remained consistent throughout the life of the animal
(Fig. 2f, l). In many cases, it appeared that multiple myelinated
axons (Fig. 2j; red arrow) or a myelinated axon and a bundle of
unmyelinated axons (Supplementary Fig. 2g,j; blue arrow), were
joined together by long thin processes of SC cytoplasm. This
suggests that mutant SCs may be assuming a branched 3D
morphology and that static cross-sectional imaging may not give
a complete representation of the phenotype. Furthermore, 2D
imaging may underestimate the proportion of SCs exhibiting
enhanced myelinating potential.
To visualize the 3D architecture of mutant SCs, we took two
parallel approaches. To examine the myelinating potential of
individual SCs lacking Fbxw7, we prepared dissociated SC/dorsal
root ganglia sensory neuron co-cultures from Dhhcre(+);Fbxw7fl/fl
and littermate control mouse embryos. In all Dhhcre(+);Fbxw7fl/fl
co-cultures we observed a low incidence of MBP+/Krox20+ SCs
with more than three MBP+ processes, which did not appear in
any of the control conditions (Fig. 3a–d). In a few instances
Fbxw7 mutant SCs displayed a highly branched morphology and
appeared to interact with more than five axons simultaneously
(Fig. 3c).
We also performed serial block-face scanning electron micro-
scopy (SBF-SEM) to visualize a mutant nerve in 3D (N= 1
Dhhcre(+);Fbxw7fl/fl nerve; 11 different regions within the nerve).
We found that in most individual cross-sections, myelinating cells
appear to display the normal 1:1 SC:axon relationship. However,
when we assessed the 3D architecture of different portions of the
mutant nerves, it became clear that Fbxw7 mutant SCs that look
normal in one plane display phenotypes indicative of enhanced
myelinating potential in other sections. For example, an Fbxw7
mutant non-myelinating SC is observed extending a thin
cytoplasmic process (Fig. 3e) in one plane that appears to join
a myelinated axon in another plane (Fig. 3f; Supplementary
Movie 1).
Multipolar cells in Fbxw7 mutant nerves are not OLs. In order
to test the possibility that the multipolar SCs observed in Fbxw7
mutants might represent OLs that migrated into peripheral
nerves, we asked whether the aberrantly myelinating cells in our
mutant nerves had characteristics of bona fide SCs or OLs.
Importantly, in both types of aberrant SC-axon interactions in
Fbxw7 mutants, we were able to trace continuous SC cytoplasm
and basal lamina on the abaxonal surface of the mutant SC (e.g.,
Fig. 2h, inset, white arrowhead). SCs secrete a basal lamina and
OLs do not; thus, the presence of a basal lamina strongly supports
the notion that these cells are indeed SCs and not OLs that might
have infiltrated the PNS. In addition, our co-culture experiments
clearly demonstrate the ability of MBP+/Krox20+ cells (a
molecular signature of SCs) to myelinate multiple axonal seg-
ments (Fig. 3a–c). These data suggest that the enhanced myeli-
nating potential observed in Fbxw7 mutants is not due to OL
infiltration. Together with the morphological analyses of Fbxw7
mutant SCs in vivo and in vitro, these data suggest that SCs
lacking Fbxw7 become multipolar and myelinate or interact with
multiple axons simultaneously in a manner reminiscent of OL
myelination.
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Fig. 1 Fbxw7 is a cell autonomous regulator of SC number and myelin thickness. a–j Transmission electron micrographs (TEMs) and quantification of SC-
specific Fbxw7mutant mice at P3 (a–e) and P42 (f–j). At P3, loss of Fbxw7 leads to increased SC number (d; nuclei pseudocolored in purple in micrographs;
p= 0.0224(*), p= 0.0015(**); one-way ANOVA) and percentage of myelinated axons (e; p= 0.0421(*), p= 0.0091(**), one-way ANOVA) in both Dhhcre
(+);Fbxw7fl/+ (Het [heterozygous]) and Dhhcre(+);Fbxw7fl/fl (cKO [conditional knockout]) nerves compared with littermate controls. However, by P42, both
of these phenotypes have been resolved (i—Control to Het p= 0.7085, Control to cKO p= 0.8578, Het to cKO p= 0.9470; j—Control to Het p= 0.9583,
Control to cKO p= 0.8507, Het to cKO p= 0.9719; one-way ANOVA for i and j). Mutant SCs also make thicker myelin as evidenced by decreased g-ratios
(k–n), especially on small diameter axons (n; 0–2 μm—p= 0.0010(***), p < 0.0001(****); 2–4 μm—p= 0.0022(**), p < 0.0001(****); two-way ANOVA).
Insets are zoomed images of the area indicated by blue boxes. Asterisks above bars indicate comparisons with controls. Comparisons between Dhhcre(+);
Fbxw7fl/+ and Dhhcre(+);Fbxw7fl/fl were not significant (p > 0.05). P3: N= 4 control, 6 Dhhcre(+);Fbxw7fl/+, 5 Dhhcre(+);Fbxw7fl/fl. P42: N= 4 control, 3
Dhhcre(+);Fbxw7fl/+, 4 Dhhcre(+);Fbxw7fl/fl. Error bars depict S.D.
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Loss of Fbxw7 in SCs causes mild motor and sensory deficits.
Given the ultrastructural phenotypes observed in Dhhcre(+);
Fbxw7fl/+ and Dhhcre(+);Fbxw7fl/fl nerves, we next assessed the
functional consequences of loss of Fbxw7 in SCs. To this end, we
performed a battery of motor and sensory behavioral analyses
using Dhhcre(+);Fbxw7fl/fl mice and their littermate controls at
6 months of age (Supplementary Fig. 3a–k). We found that the
Dhhcre(+);Fbxw7fl/fl mice displayed modest behavioral deficits. In
the vertical pole test, Dhhcre(+);Fbxw7fl/fl mice took longer to
climb down the pole than their control siblings, suggesting a mild
defect in complex motor behavior15,16 (Supplementary Fig. 3e, f).

















































































Fig. 2 Loss of Fbxw7 enhances the myelinating capacity of SCs. TEM of SC-specific Fbxw7 mutant mice show aberrant SC-axon interactions as early as P3
(a–f) and continuing until at least P180 (g–l). SCs lacking Fbxw7 appear to myelinate multiple axons (b, c, j) as well as generate myelin while
simultaneously extending processes to encompass small-caliber non-myelinated axons (d, e, h, i). In Het nerves, ~4% of SCs myelinated multiple axons
while another 7–8% appeared to be myelinating/Remak hybrids (f, l; Het multi-axonal myelination p= 0.0063 (P3) p < 0.0001 (P150–180); Het
myelinating/Remak hybrids p < 0.0001 (P3 and P150–180)). The percentage of SCs displaying these phenotypes in cKO nerves was similar at both P3 and
P150–180 (f, i; cKO multi-axonal myelination p= 0.0382 (P3), p < 0.0001 (P150–180); cKO myelinating/Remak hybrids p < 0.0001 (P3 and P150–180);
ANOVA). In both phenotypes there was continuous basal lamina (white arrowhead) around these cells and their processes (h, inset), and it was the outer
cytoplasmic pocket that extended these additional processes (d; white arrow). In aged nerves, some SCs still appeared to be myelinating/Remak hybrids
(i; SC cytoplasm pseudocolored in red). The true proportion of mutant SCs displaying these behaviors is likely underestimated by cross-sectional analyses
(f, l) as multiple myelinated axons appeared to be joined by very thin cytoplasmic processes (k; SC cytoplasm pseudocolored in blue). P3: N= 4 control, 6
Dhhcre(+);Fbxw7fl/+, 5 Dhhcre(+);Fbxw7fl/fl. P150–180: N= 5 control, 4 Dhhcre(+);Fbxw7fl/+, 5 Dhhcre(+);Fbxw7fl/fl. Asterisks above bars indicate comparisons
with controls; comparisons between Dhhcre(+);Fbxw7fl/+ and Dhhcre(+);Fbxw7fl/fl were not significant (p > 0.05). m=myelinated axon; a= unmyelinated
axon. Error bars depict S.D.
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but significant decrease in the maximum contact intensity (Sup-
plementary Fig. 3g) and print area (Supplementary Fig. 3h) of the
fore paws of Dhhcre(+);Fbxw7fl/fl mice. In addition, mutant ani-
mals trended towards a mild hypersensitivity to cold induced by
the evaporative cooling of acetone applied to the hind paw17
(Supplementary Fig. 3k), although this result did not reach sta-
tistical significance (p= 0.0977).
Fbxw7 regulates mTOR to control SC number, myelination,
and Remak bundle organization. To our knowledge, no genetic
or pharmacological manipulation in vivo has been reported to
increase the myelinating ensheathment potential of SCs in the
manner observed in Fbxw7 mutants. However, the hypermyeli-
nation and defects in Remak bundle size observed in Fbxw7
mutants have been described following SC-specific deletion of
Pten18 or overactivation of Akt19, which both result in elevated
mTOR signaling. Previous reports show loss of Fbxw7 function
enhances levels of mTOR and its targets20, and Fbxw7 was
recently shown to regulate mTOR in CNS myelination7.
Therefore, we examined levels of mTOR and found that total
mTOR protein levels are ~2-fold higher in Fbxw7 mutants
relative to controls (Fig. 4a, b). Similarly, and consistent with
previous findings that multiple feedback loops regulate the PI3K/
mTOR pathway21, we found that the mRNA levels of mTOR as
well as several targets of mTOR were also significantly elevated in
Fbxw7 mutant nerves (Fig. 4c).
To directly test if Fbxw7 controls mTOR in SCs, we generated


































Fig. 3 Fbxw7 mutant SCs display branched 3D morphology. Dissociated SC/DRG co-cultures from control (a) and Dhhcre(+):Fbxw7fl/fl (b, c) mouse
embryos indicate that WT MBP(+) SCs are bipolar (a), whereas mutant SCs can assume a multipolar morphology (b) sometimes with highly branched
processes (c). These phenotypes did not occur in the control cultures (d; p= 0.0099, unpaired t-test with Welch’s correction). Data are quantified per
490.88mm2 and represent two technical replicate cultures from each of three independent mouse embryos per genotype. Scale bar is 20 μm. Serial block-
face scanning electron microscopy (SBF-SEM) images of a Dhhcre(+):Fbxw7fl/fl nerve at P150 (e–h). A mutant SC extends a thin cytoplasmic process
between an unmyelinated axon (marked by a) to a myelinated axon (marked by m) (e; white box denotes the area shown in (f); cyan asterisk is for
reference). In some sections we see that the process is distinct and does not touch the membrane around the myelinated axon (f; yellow dotted line
denotes cell membranes; cyan asterisk for reference). However, in other sections it is clear that these two axons are joined by continuous cytoplasm (g, h).
SBF-SEM images shown here are stills from Supplementary Movie 1. Error bars depict S.D.
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mice22 to our Dhhcre(+);Fbxw7fl/fl mice (Supplementary Figs. 4
and 5). We were unable to obtain enough Dhhcre(+);Fbxw7fl/fl;
mTORfl/fl mutants from trans-heterozygous intercrosses (1/32
expected, 1/126 obtained (Fig. 5g, h)); therefore, we analyzed
Dhhcre(+);Fbxw7fl/+;mTORfl/fl (HetΔmTOR) animals in more
detail as the Fbxw7 mutation is dominant. For the epistasis
experiments, Dhhcre(−);Fbxw7fl/+;mTORfl/+ and Dhhcre(−);
Fbxw7fl/+;mTORfl/fl siblings were used as controls.
If mTOR is the Fbxw7 target responsible for the SC defects
observed in Fbxw7 mutants, loss of mTOR should suppress
these phenotypes in Dhhcre(+);Fbxw7fl/+ animals. Indeed, at
P3, Dhhcre(+);Fbxw7fl/+;mTORfl/fl animals were indistinguish-
able from controls with regard to SC numbers and the
percentage of myelinated axons (Supplementary Fig. 4a–e). At
P21, Remak bundles in Dhhcre(+);Fbxw7fl/+;mTORfl/fl nerves
contained significantly more axons relative to Remak bundles in
either controls or Fbxw7 mutants (Supplementary Fig. 4f–j).
Further, in agreement with previous studies23, Dhhcre(+);
Fbxw7fl/+;mTORfl/fl nerves were hypomyelinated relative to
controls and Dhhcre(+);Fbxw7fl/+ animals (Supplementary
Fig. 4k), demonstrating that mTOR is epistatic to Fbxw7. These
data suggest that Fbxw7 regulates mTOR to control early SC
number, axon ensheathment by Remak SCs, and myelin
thickness.
SC myelinating potential is independent of mTOR signaling.
Given that mTOR mediated the many of the SC developmental
defects observed in Fbxw7 mutants we next tested whether it also
mediated the phenotype of multiple axon ensheathment by
myelinating SCs. Strikingly, loss of mTOR in Fbxw7 mutant SCs
appeared unable to restore normal SC myelinating potential.
Despite the fact that Dhhcre(+);Fbxw7fl/+;mTORfl/fl nerves had
normal numbers of SCs, delayed radial sorting, larger Remak
bundles, and thinner myelin, loss of mTOR appeared to be
insufficient to suppress the enhanced myelinating potential
observed in Fbxw7 mutant SCs. Double mutant myelinating SCs
were still seen ensheathing multiple axons, as well as displaying
myelinating/Remak hybrid phenotypes (Fig. 5). As in the Dhhcre
(+);Fbxw7fl/+ and Dhhcre(+);Fbxw7fl/fl animals, mutant SCs in
Dhhcre(+);Fbxw7fl/+;mTORfl/fl and Dhhcre(+);Fbxw7fl/fl;mTORfl/fl
nerves that had already myelinated large axons were seen
extending processes from the outer cytoplasmic pocket to interact
with other axons (Fig. 5c, f; white arrowhead). These data suggest
that Fbxw7 controls SC myelinating potential independent of
mTOR signaling. It is remarkable that SC myelinating capacity
appears to remain enhanced in Dhhcre(+);Fbxw7fl/+;mTORfl/fl
mutants despite the fact that deletion of mTOR caused several
defects in peripheral nerve development. This suggests that the


































































































































Fig. 4 mTOR levels are elevated in Fbxw7 mutants. Western blot analyses of sciatic nerve lysates indicate a 2-fold increase in mTOR protein in Dhhcre(+):
Fbxw7fl/fl (cKO [conditional knockout]) nerves compared with littermate controls when normalized to both background and alpha-tubulin levels (a, b; p=
0.0350, unpaired t-test with Welch’s correction). mTOR mRNA is also upregulated in Dhhcre(+):Fbxw7fl/fl nerves (c; mTOR p= 0.0236, Eif4b p= 0.417,
Eif4ebp1 p= 0.0398, Eif4ebp2 p= 0.0087, Prkca p= 0.0073; #= p < 0.1; one-way ANOVA), as are multiple mTOR targets. The gray line at y= 1 denotes
control levels. For western blots: N= 5 controls, N= 5 Dhhcre(+):Fbxw7fl/fl at P42. For qPCR, N= 3 control and 3 Dhhcre(+):Fbxw7fl/fl at P21. Error bars
depict S.D.
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SCs are distinct from the cellular behaviors involved in radial
sorting, myelination, or Remak SC ensheathment.
c-Jun is elevated in Fbxw7 mutant SCs. To begin to assess the
possible molecular mechanism underlying the enhanced
ensheathing potential of mutant myelinating SCs, we mined
previously generated RNA sequencing (RNAseq) data from wild-
type sciatic nerves at P3 and P2124 to determine if any other
Fbxw7 targets are expressed in SCs. In addition to mTOR, we
found that several other well-known targets of Fbxw7 including c-
Jun25, Notch, and Cyclin E are also expressed in normal sciatic
nerves at P3 and P21 (Fig. 6a). c-Jun stood out among these
possible targets because it is required for the acquisition of the
repair SC phenotype26–28, the multipolar morphology assumed
by Fbxw7 mutant SCs is reminiscent of branched repair SCs29,
and loss of Fbxw7 has previously been shown to elevate c-Jun
levels30. Therefore, we tested the hypothesis that c-Jun is elevated
in Dhhcre(+);Fbxw7fl/fl relative to controls. Indeed, immuno-
fluorescent analysis of c-Jun levels at P150–180 suggests that
Dhhcre(+);Fbxw7fl/fl nerves display a greater proportion of c-Jun
positive nuclei than sibling control nerves (Fig. 6b–f). Future
epistasis experiments are required to test if inappropriate
elevation of c-Jun causes enhanced myelinating potential in
Fbxw7 mutant SCs, and aberrant c-Jun levels may explain the
morphological similarities between repair SCs and SCs that have
lost Fbxw7 function.
Altogether, our data suggest that Fbxw7 inhibits SC myelinat-
ing potential such that loss of Fbxw7 function allows SCs to
assume a multipolar branched morphology and to interact with
and appear to myelinate axons in a fashion reminiscent of OL
myelination. Further, we have shown here that this function of
Fbxw7 is independent of its regulation of mTOR, which controls
myelin thickness and some aspects of Remak SC biology. Given
that Fbxw7 mutant SCs are morphologically similar to repair SCs
and that c-Jun, a well-known regulator of the repair SC
phenotype, is elevated in mutant SCs, our current working model
is that Fbxw7 may regulate myelinating SC ensheathment
potential through inhibition of c-Jun (Fig. 7). However, Fbxw7
is known to control many different master regulators, many of
which are also expressed in SCs at similar times (Fig. 6a).
Although most have not yet been experimentally confirmed,
~1700 proteins contain one or more Fbxw7 degron motifs31 and
thus are potential targets of Fbxw7. Therefore, significant
















































Dhhcre(+); Fbxw7 fl/+; mTOR +/+
Dhhcre(+); Fbxw7 fl/fl; mTOR fl/fl
Dhhcre(+); Fbxw7 fl/+; mTOR fl/fl
Fig. 5 The ensheathment capacity of myelinating SCs is independent of mTOR signaling. mTOR deletion in Fbxw7mutant nerves failed to suppress aberrant
SC-axon interactions. Apparent multi-axonal myelination and SCs that appeared to both myelinate and encompass multiple small non-myelinated axons
were present in both Dhhcre(+);Fbxw7fl/+;mTOR+/+ (b, e) and Dhhcre(+);Fbxw7fl/+;mTORfl/fl (HetΔmTOR) (c, f) nerves. Neither phenotype was ever
observed in sibling controls (a, d; p < 0.0001(****); ANOVA). Tracing the BL (e, f; white arrows) suggested these behaviors were the acts of single SCs.
Both phenotypes were also present in the sole Dhhcre(+);Fbxw7fl/fl;mTORfl/fl (cKOΔmTOR) animal we were able to collect (g, h). Asterisks above bars
indicate comparisons with controls; comparisons between Dhhcre(+);Fbxw7fl/+ and Dhhcre(+);Fbxw7fl/+;mTORfl/fl were not significant. P3: N= 4 control, 6
Dhhcre(+);Fbxw7fl//+;mTOR+/+, 5 Dhhcre(+);Fbxw7fl/+;mTORfl/fl, 1 Dhhcre(+);Fbxw7fl/fl;mTORfl/fl. m=myelinated axon; a= unmyelinated axon. Error bars
depict S.D.
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mechanisms underlying the regulation of SC myelinating
potential by Fbxw7.
Discussion
In stark contrast to OLs in the CNS, which can myelinate dozens
of axon segments simultaneously, myelinating SCs are restricted
to myelinating a single axonal segment in the PNS. The molecular
mechanisms controlling the differences in myelinating potential
between SCs and OLs remain mysterious. Here we show that SCs
are capable of myelinating multiple axons in vivo and challenge
the notion that the ability of a SC to extend multiple processes is
mutually exclusive with the capacity to make myelin. Remak SCs
are also capable of extending multiple processes and interacting
with many axons, but unlike OLs they do not myelinate axons.
However, upon loss of Fbxw7, single SCs can simultaneously
myelinate some axons, while also appearing to encompass
unmyelinated axons as if mutant SCs are hybrids between
myelinating SCs and Remak SCs. Further, the multipolar, bran-
ched 3D morphology and apparent multi-axonal myelination
observed in Fbxw7 mutant SCs is reminiscent of OL myelination.
However, the presence of basal laminae and presence of SC-
lineage markers suggests that OLs have not infiltrated Fbxw7
mutant nerves.
Although neither of the aberrant Fbxw7 mutant SC-axon
interaction phenotypes have been previously described in vivo,
several other phenotypes observed in Fbxw7 mutant nerves
resemble phenotypes described in mutants where mTOR signal-
ing is enhanced such as in Pten mutants18 and constitutively
active Akt mutants19. It is well documented, from these studies
and others, that mTOR levels must be tightly regulated in SCs
such that any type of manipulation results in defective PNS
myelination18,19,23,32–37. mTOR is a bona fide target of Fbxw7 in
other contexts20, and Fbxw7 was recently shown to control OL
myelination through mTOR7. Thus, we tested the hypothesis that
Fbxw7 regulates mTOR to control SC development. We showed
that mTOR and some of its targets are upregulated in Fbxw7
mutants, suggesting that mTOR activity is elevated. Double
transgenic analyses demonstrated that mTOR is epistatic to
Fbxw7 and is responsible for regulating early SC numbers, Remak
bundle organization, and appropriate myelin thickness.
Notably, however, loss of mTOR in Fbxw7 mutant SCs did not
restore typical SC:axon ratios. Despite the fact that Dhhcre(+);
Fbxw7fl/+;mTORfl/fl nerves had normal numbers of SCs, delayed
radial sorting, larger Remak bundles, and thinner myelin, loss of
Fbxw7 was nevertheless sufficient to appear to drive increased
myelinating potential of SCs. This suggests that the myelinating
potential of SCs is independent of mTOR signaling, and impor-
tantly, that the mechanisms controlling the typical SC:axon ratio
is also controlled independently from other morphological
behaviors of SCs, including radial sorting, Remak SC ensheath-












































































Fig. 6 c-Jun is elevated in Fbxw7 mutant nerves. Previously published RNAseq data24 from WT sciatic nerves at P3 and P21 was mined to reveal that, in
addition to Fbxw7 itself and mTOR, several other well-known targets of Fbxw7 are expressed during SC development (a). Immunofluorescence studies of
control (b, c) and Dhhcre(+);Fbxw7fl/fl (d, e; white arrows indicate c-Jun positive nuclei; cKO) nerves at 6 months. cKO nerves display nearly three times the
proportion of c-Jun+ nuclei relative to controls (f; p= 0.0025 (**), unpaired t-test with Welch’s correction). N= 3 per genotype. Error bars depict S.D.
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When we mined RNAseq data, we found that several well-
known targets of Fbxw7 are also expressed in SCs during early
development. One of these was the transcription factor c-Jun,
which is an important molecular switch that must be upregulated
after injury for SCs to properly assume repair SC phenotypes27,28.
Interestingly, repair SCs adopt a branched morphology during
nerve regeneration29 that resembles the multipolar 3D archi-
tecture we observed in Fbxw7 mutant SCs. Although it is
expressed at a low level in SCs, c-Jun is dispensable in normal
nerves and thus c-Jun protein is often barely detectable except in
cases of nerve injury27,28. Recent evidence also suggests that
mTOR is transiently reactivated after nerve injury to promote
the elevation of c-Jun33. Therefore, we hypothesized that c-Jun
might be aberrantly upregulated upon loss of Fbxw7, possibly
leading mutant SCs to assume a branched morphology similar to
that of repair SCs. Indeed, we found that c-Jun levels in nerves
from Dhhcre(+);Fbxw7fl/fl mice were nearly three times that of
controls. Thus, future efforts will determine if developmental
regulation of c-Jun by Fbxw7 controls SC myelinating potential.
However, our work highlights the complicated nature of losing
function of a protein like Fbxw7, which is a regulator of master
regulators. Given the role of Fbxw7 in E3 ubiquitin ligase com-
plexes, it is possible that dysregulation of c-Jun is causal for the
aberrant SC phenotypes we observe. It is also possible that the
complex phenotypes present in Fbxw7 mutant nerves result
from combinatorial interactions amongst multiple misregulated
targets.
Future work should also explore the implications of enhanced
myelinating potential on remyelination after PNS injury. In
contrast to SC remyelination, OL remyelination and CNS
recovery after injury is limited in mammals, and OLs do not de/
redifferentiate to aid in recovery38. One interesting hypothesis is
that the distinction between the ability of SCs vs. OLs to facilitate
repair after injury is rooted in fundamental qualities that distin-
guish these cells, such as the number of axons they associate with
and myelinate. It is now clear that OLs interpret and respond to
neuronal activity by selective myelination and that OLs play a
critical role in circuit development, refinement and/or main-
tenance39–42. It is intriguing to speculate that OLs may link cir-
cuits through their interactions with and myelination of multiple
axons. However, in the PNS, where circuits are less complex,
there is not strong evidence for SC participation in active mod-
ulation of circuit function. Rather, more emphasis seems to be
placed on the ability of SCs to rapidly and faithfully respond to
injuries, which occur more readily in the PNS. Presumably, this
rapid response would be more difficult if SCs were required to
demyelinate more than one axon, especially if only some of those
axons were injured, while others were intact. Fbxw7 mutants
represent a unique and useful tool with which to investigate the
impact of differences between myelinating SCs, Remak SCs, and
OLs on nervous system repair. Moreover, our work demonstrates
a previously unknown plasticity of SCs and suggests that the
demarcation between the cell biology of SC and OL myelination
may be less rigid than previously appreciated.
Methods
Contact for reagents and resource sharing. Requests for further information,
resources, and reagents should be directed to and will be fulfilled by Kelly Monk
(monk@ohsu.edu).
Experimental model and subject details. All animal experiments were performed
in compliance with institutional ethical regulations for animal testing and research
at Washington University, Oregon Health and Science University (OHSU), and
University of California San Francisco (UCSF). Experiments were approved by the
Animal Care and Use Committee of Washington University School of Medicine
(St. Louis, MO), the Institutional Animal Care and Use Committee of OHSU
(Portland, OR), and the Institutional Animal Care and Use Program of UCSF (San
Francisco, CA).
The Fbxw7 conditional-ready mice (Fbxw7fl/fl)11 were obtained from Jackson
laboratories (Stock #: 017563) on a pure C57BL/6 background. Fbxw7fl/fl mice were
mated to DhhCre(+) mice10 that had also been maintained on a pure C57BL/6
background (>7 generations) to generate DhhCre(+);Fbxw7fl/+ (Het) mice. Fbxw7
Hets were backcrossed to Fbxw7fl/fl animals to obtain DhhCre(+);Fbxw7fl/fl (cKO)
mice. For all cKO experiments, we used DhhCre(−);Fbxw7fl/+ or DhhCre(−);
Fbxw7fl/fl littermates as controls. For the double mutant experiments with Fbxw7
and mTOR, we obtained mTOR conditional-ready (mTORfl/fl) mice43 from
Jackson laboratories (Stock #: 0110009), also on a pure on C57BL/6 background.
The mTORfl/fl mice were crossed with DhhCre(+);Fbxw7fl/fl animals to generate
DhhCre(+);Fbxw7fl/+;mTORfl/+ animals. Finally, to obtain double mutants, we
crossed DhhCre(+);Fbxw7fl/+;mTORfl/+ to DhhCre(−);Fbxw7fl/+;mTORfl/+ animals
and analyzed DhhCre(+);Fbxw7fl/+;mTORfl/fl animals (“HetΔmTOR” for brevity).
In all cases, mice of both sexes were analyzed, in equal ratios whenever possible. In
all cases mutants were compared with littermate sibling controls.
All mouse lines were genotyped as previously described10,11,43.
Transmission electron microscopy (TEM). TEM was performed on mouse sciatic
nerves at P3, P21, P42 and ≥6 months44. Nerves were immersion-fixed in modified
Karnovsky’s fixative (4% PFA, 2% glutaraldehyde, 0.1 M sodium cacodylate, pH
7.4) at least overnight at 4 °C. Samples were then washed with 0.1 M sodium
cacodylate to remove fixative, and then post-fixed for 1 h in 2% osmium tetroxide
in 0.1 M sodium cacodylate. Nerves were then dehydrated with increasing con-
centrations of ethanol followed by propylene oxide (PO). Samples were then
infiltrated for 1–2 h in 2:1 PO:EPON, and then overnight in 1:1 PO:EPON with
gentle agitation at room temperature. Samples were then transferred to 100%
EPON while residual PO was allowed to fully evaporate (>4 h). For all time points,
four non-overlapping images at ×1000 magnification were quantified, and all
mouse TEM data is expressed per 1000 μm2 area. Control genotypes were DhhCre
(−);Fbxw7fl/+ and DhhCre(−);Fbxw7fl/fl. For P3: N= 4 controls, N= 6 DhhCre(+);
Fbxw7fl/+ (Hets), and N= 5 DhhCre(+);Fbxw7fl/fl (cKO). At P21: N= 4 controls, N






































Fbxw7 deficient Schwann cells
Fig. 7 Fbxw7 orchestrates SC biology via mTOR-dependent and -independent
mechanisms. Artistic renditions of the phenotypes observed in Fbxw7 mutant
SCs (right) as compared with normal SCs (left). Fbxw7 is involved in radial
sorting (top), as well as both mature myelinating SCs (middle) and Remak
SCs (bottom). A simplified PI3K/mTOR pathway shows that in SCs, Fbxw7
directly inhibits mTOR, and thus regulates multiple aspects of SC biology.
Fbxw7 may regulate SC myelinating potential through its control of c-Jun.
Steps in the pathway that were not demonstrated directly in this study are
shown in gray. Pencil sketches by B.L.H.
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cKO. At 6 months of age: N= 5 controls, N= 4 Hets, and N= 5 cKO. For the
double mutant analyses, control genotypes used were DhhCre(−);Fbxw7fl/+;mTOR
+/+ DhhCre(−);Fbxw7fl/+;mTORfl/fl, DhhCre(−);Fbxw7fl/+;mTORfl/+, DhhCre(−);
Fbxw7fl/fl;mTORfl/fl, and DhhCre(−);Fbxw7+/+;mTORfl/fl. Fbxw7 “Hets” were
DhhCre(+);Fbxw7fl/+;mTOR+/+ littermate siblings, and “HetΔmTOR” animals were
DhhCre(+);Fbxw7fl/+;mTORfl/fl siblings. At P3: N= 4 controls, N= 6 Hets, N= 5
HetΔmTOR, and N= 1 DhhCre(+);Fbxw7fl/fl;mTORfl/fl (cKOΔmTOR). For P21: N
= 6 controls, N= 4 Hets, and N= 3 HetΔmTOR.
Serial block-face scanning electron microscopy (SBF-SEM). SBF-SEM was
performed on a DhhCre(+);Fbxw7fl/fl nerve at P180 (N= 1; multiple regions).
Nerves were fixed in 4% PFA overnight at 4 °C. Nerves were then processed for
SBF-SEM by the Multiscale Microscopy Core at Oregon Health & Science Uni-
versity. Images were collected with 10 nm lateral resolution and 50 nm slice
thickness using an FEI Teneo VolumeScope Microscope. Nerves were sectioned
and imaged overnight to obtain a depth of ~50 μm. Eleven different regions of
interest were imaged and analyzed across two technical experiments. Sections were
annotated using FIJI, the movie was composed using Microscopy Image Browser
software, and data compilation was performed using Amira. The movie shown is a
representative example.
Behavioral studies. Behavior testing was performed using mice of both sexes from
5 to 6 months of age (N= 11 controls, N= 10 cKO). The experimenter was blind
to the genotypes of the mice during all data acquisition. All behavior data was
analyzed using a t-test with Welch’s correction to determine statistical significance.
Gross motor function (Rotarod). An accelerating Rotarod (Ugo Basile, Comerio,
Italy) as used to assess motor coordination45. Mice received two training sessions
separated by 1 h. The first training session consisted of two trials of 120 s spent
walking on the Rotarod at a fixed spped of 4 r.p.m. The second training session
consisted of one trial of 120 s at 4 r.p.m. Latency to fall as the Rotarod accelerated
from 4 to 40 r.p.m. over 5 min was assessed. Five consecutive experimental trials
were performed with a 5 min rest interval between trials.
Locomotor activity (open field). Prior to testing, mice were habituated to the test
room in their cages for 1 h. Locomotor activity in an open field16 was then assessed
by recording photo beam breaks in a 42 (length) × 42 (width) × 30 (height) cm
chamber for 60 min using a VersaMax Animal Activity Monitoring System
(AccuScan Instruments). We then calculated the total distance traveled and the
horizontal activity (beam breaks) over the entire chamber.
Movement initiation. To assess movement initiation, we recorded the time it took
each mouse to exit an 18 × 18 cm square (all four paws outside the square) marked
on a flat horizontal surface.
Complex motor function (pole test). We used the pole test to evaluate perfor-
mance of a complex motor task that requires skilled forelimb use, strength, and
balance15. Mice were placed on a vertical metal pole that is 49 cm in height and 0.9
cm in diameter with the head of the mouse oriented upward. The time required for
the mouse to turn around such that the mouse’s head is oriented downward and
the hind limbs are straddling the pole was recorded. In addition, the time required
for the mouse to climb down to the base of the pole was recorded.
Cold sensitivity (acetone evaporation test). Cold sensitivity of the hind paws
was measured by applying a drop of acetone to the plantar surface of the hind paw.
Five separate applications of acetone were applied to each hind paw. For each
application the mouse was observed for 5 min. The percentage of applications for
which the mouse responded (shaking, licking, or elevating the hind paw) to acetone
application was recorded for each mouse17.
Gait analysis. We used the Noldus CatWalk XT system to quantify multiple
locomotor and gait parameters including: run speed, stride length, paw print area
(mm2), maximum contact area (mm2), and maximum contact mean intensity
(arbitrary units [a.u.]). Briefly, the mouse voluntarily traverses a meter-long glass
plate and its footprints are captured by a video camera. CatWalk XT quantifies
parameters related to print dimensions and gait dynamics.
Mechanical sensitivity (von Frey). The innocuous mechanical thresholds of both
hind paws were assessed with the von Frey test. Mice were placed in plastic
behavior boxes with open bottoms on a wire mesh. Varying diameter von Frey
monofilaments (Stoelting, Chicago, IL) were pressed against the plantar surface of
the hind paw until the filament bent. The force applied to the hind paw is
dependent on the diameter of the filament. The up/down method described by
Chaplan was used to determine the withdrawal threshold46.
Heat sensitivity (Hargreaves). Heat sensitivity was evaluated by using a paw
thermal stimulation system in which a source of radiant heat (active intensity= 15)
was applied to the plantar surface of the hind paw and the paw withdrawal latency
was measured47. We performed three trials on each paw. The withdrawal latencies
obtained in each of the six trials were averaged to obtain the withdrawal latency for
each mouse.
Myelinating Schwann cell cultures. Dissociated SC/dorsal root ganglia (DRG)
sensory neuron co-cultures were prepared as previously described48–50. Briefly,
DRGs were isolated from individual embryonic day 13.5 (E13.5) DhhCre(−);
Fbxw7fl/fl (control) or DhhCre(+);Fbxw7fl/fl (cKO) mouse littermate embryos. DRGs
were washed with L15 medium and then incubated in 0.25% trypsin at 37 °C for 30
min. Trypsin was removed, and DRGs were washed with L15+ 10% FBS and
centrifuged gently at 1000 r.p.m. for 10 min. The medium was replaced with DRG
medium (high glucose MEM with 10% FBS and 100 ng/mL NGF), and DRGs were
triturated with a fire-polished Pasteur pipette until homogenous. The suspension
was plated at 150,000 cells in the center of a collagen-coated 25 mm coverslip.
Cultures were maintained in DRG medium for 5–6 days, after which 50 µg/mL
ascorbic acid was added to the medium to induce myelination. Cultures were fixed
in 4% PFA for 15 min after ten days in media containing ascorbic acid. Cultures
were blocked and permeabilized with 20% normal goat serum (NGS) and 0.2%
Triton X-100 in PBS for 1 h at room temperature, and then incubated overnight at
4 °C with the following antibodies in 20% NGS: mouse anti-neurofilament medium
chain (1:200; Millipore), rat monoclonal anti-MBP (1:100; Millipore), and rabbit
anti-Krox20 (1:500; provided by Dies Meijer). Cultures were then incubated with
Alexa Fluor AffiniPure goat anti-mouse 488 (1:1000), AffiniPure goat anti-rat 594
(1:1000), and goat anti-rabbit 647 (1:500) for 1 h at room temperature, counter-
stained with DAPI, and dried before mounting in Prolong Gold Mountant (Invi-
trogen). Cultures were imaged as z-stacks using a ×40 oil 1.3NA objective on a
Zeiss AxioImager with ApoTome. Entire cultures were imaged and analyzed by an
experimenter blinded to genotype, and counts represent the number of multipolar
MBP(+)/Krox20(+) SCs per culture. Data represent two technical replicate cul-
tures from each of three independent mouse embryos per genotype.
Western blot analyses. To assess mTOR protein levels in the sciatic nerve, we
dissected nerves from the sciatic notch to just proximal to the trifurcation. These
nerve segments were flash-frozen in liquid nitrogen, cut into small pieces with
microdissection scissors, and homogenized in lysis buffer (20 mm Tris-HCl, pH
7.5, 150 mm NaCl, 1 mm Na2EDTA, 1 mm EGTA, 1% Triton X-100, 2.5 mm
sodium pyrophosphate, 1 mm β-glycerophosphate, 1 mm Na3VO4, 1 μg/ml leu-
peptin) with phosphatase inhibitor mixtures 1 and 2 (Invitrogen, ThermoFisher
Scientific, Waltham, MA). Equal protein amounts (15 μg) were loaded and ana-
lyzed by SDS-PAGE and western blot. Antibodies used were anti-mTOR (1:1000;
Cell Signaling Technologies, Danvers, MA) and anti-α-tubulin (1:1000; Abcam,
Cambridge, MA). Western blot images were quantified using FIJI. All bands were
normalized to background and mTOR bands were compared with α-tubulin levels.
RNA isolation and reverse transcription. Total RNA was extracted from flash-
frozen P21 mouse sciatic nerves (N= 3 DhhCre(−);Fbxw7fl/fl littermate controls and
N= 3 DhhCre(+);Fbxw7fl/fl animals), using a standard TRIzol extraction protocol
(Life Technologies, ThermoFisher Scientific, Waltham, MA). Briefly, TRIzol was
added to the frozen tissue samples, which were then allowed to thaw at room
temperature for 10 min. During this incubation time, and while still in TRIzol,
nerves were cut into much smaller pieces using microdissection scissors. Samples
were homogenized via disruption with a plastic-tipped electric homogenizer, fol-
lowed by passage through a syringe and 22.5 g needle at least ten times, and then a
27 g needle at least ten more times until no lumps of tissue were observed. Once the
nerves had been homogenized, we proceeded as usual with the standard TRIzol
RNA extraction procedure as per manufacturer instructions.
Total RNA (500 ng) was then reverse transcribed in 20 μl using the Superscript
III First Strand cDNA Synthesis Kit (Invitrogen, ThermoFisher Scientific,
Waltham, MA) using random hexamers, as per manufacturer instructions. All
cDNA products were diluted 1:5 prior to use in qPCR reactions.
Quantitative reverse transcription PCR. To assay mRNA expression levels of
mTOR and members of the mTOR signaling pathway, we used the RT2 Profiler
PCR Array for Mouse mTOR Signaling (Qiagen, PAMM-098ZA, Valencia, CA). A
complete gene list can be found on the manufacturer’s website. All assays were
performed on a ViiA7 Real-Time PCR system (Applied Biosystems, ThermoFisher
Scientific, Waltham, MA), in a total volume of 10 μl using 2X SsoFast Evagreen
Supermix (BioRad, Hercules, CA) and 50 ng of cDNA per reaction. Standard qPCR
settings were used: 95 °C for 10 min followed by 40 cycles of 95 °C for 15 s (sec)
then 60 °C for 30 s, followed by melt curve analysis. As suggested by the RT2
profiler manual, we adjusted the ramp rate to 1 °C/s. All controls including
housekeeping genes, positive controls for amplification, and controls for genomic
DNA contamination were included as standards in the array.
qPCR data were analyzed using Microsoft Excel. Relative expression was
calculated using the ΔΔCt method51. Genomic contamination was negligible in all
samples. To control for input variations, ΔCt was calculated by comparing the Ct of
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each gene of interest (GOI) to the average Ct of the five housekeeping genes (Actb,
B2m, Gapdh, Gusb, and Hsp90ab1) for that sample. ΔΔCt was then calculated
relative to expression compared with that seen in the littermate control. Average
relative expression (RQ), or fold change (2−ΔΔCt), over controls is shown in
Fig. S3. All error bars depict RQmax and RQmin, which represent the maximum
and minimum limits of possible RQ values based on the standard error of the ΔCt
values. The gray line at y= 1 represents the controls.
RNA sequencing data mining. To analyze the expression of Fbxw7, mTOR, and
other Fbxw7 targets, we mined previously reported RNA sequencing data24 from
wild-type sciatic nerves at P3 and P21. We generated a list of candidates through a
series of basic literature searches focusing primarily on targets of Fbxw7 that might
have a role in SCs (c-Jun, Notch, Myc, Ccne1 (cyclinE), PGC1, SREBP1, and
GATA1). This list is not intended to represent an exhaustive list of Fbxw7 targets.
Using Excel, we searched the raw data for the gene names of Fbxw7, mTOR, and
our candidate targets. We then recorded the raw FPKM value for each animal at
each time point (N= 4 for P3 and N= 3 for P21) and transferred that information
into Graphpad PRISM for analysis. We then averaged the FPKM values for each
time point, calculated the standard deviation (S.D.; error bars shown), and gen-
erated the graph shown in Fig. 6a using PRISM 8 for MacOS.
Immunofluorescence. Sciatic nerves were isolated and fixed in 4% paraf-
ormaldehyde (PFA) overnight at 4 °C. After washing with PBS and 30% sucrose,
nerves were embedded in OCT and frozen at −80 °C. Cryo-sections were acquired
in cross-section orientation at 15 μm thickness. Slices were brought to room
temperature and then incubated with blocking solution (2% bovine serum albumin,
2% normal goat serum, 0.2% Triton in 1× PBS). The following primary antibodies
were diluted in blocking solution and incubated for 2 h at room temperature: Anti-
S100 beta [EP1576Y] (Alexa Fluor 488—Abcam 1:200) and Anti-c-Jun (60A8, Cell
Signaling 1:200). Samples were then washed three times (5 min each) in 1× PBS,
and slides were incubated with secondary species-specific Invitrogen antibodies for
1 h or mounted using Vectashield with DAPI (Vector Labs) to label nuclei.
Fluorescent images were obtained with a Zeiss AxioImager microscope. CZI files
were analyzed using FIJI. All data were quantified blindly. N= 3 per genotype. c-
Jun data are shown in Fig. 6.
Quantification and statistical analysis. All data are reported as mean+ standard
deviation (S.D.). Statistically significant differences were determined using one-way
ANOVA for all experiments with more than two groups but only one dependent
variable. Similarly, two-way ANOVA was used for experiments with multiple
groups and two dependent variables. All experiments with only two groups and
one dependent variable were compared using an unpaired t-test with Welch’s
correction, which assumes unequal variance. Figure legends specify which test was
used for specific experiments. In all cases, *= p < 0.05; **= p < 0.01; ***= p <
0.001; and ****= p < 0.0001; NS= not significant. In all cases, asterisks immedi-
ately above a bar indicate the significance of that sample relative to the control
sample. If any other comparisons, such as DhhCre(+);Fbxw7fl/+ (Het) to DhhCre(+);
Fbxw7fl/fl (cKO), were significant, this is indicated with a bar spanning above the
two samples being compared with the appropriate asterisks. If not indicated
otherwise, the comparison was not significant. In most cases, DhhCre(+);Fbxw7fl/+
samples were not statistically distinguishable from DhhCre(+);Fbxw7fl/fl.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
No new genomic datasets were generated or analyzed during the current study. Raw data
from the SBF-SEM analysis will be made freely available upon request.
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